# OnCo record idea-pu-lutetium-177-family-planning-table (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-pu-lutetium-177-family-planning-table/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-pu-lutetium-177-family-planning-table" ;
  schema:name "One aligned table of contraception and breastfeeding intervals after lutetium-177 therapy"@en ;
  schema:description "After lutetium-177 treatment for prostate cancer or neuroendocrine tumours, patients are told how long to avoid pregnancy or breastfeeding, but the numbers differ by source: 3 months, 14 weeks, 4 months, 6 months or 7 months. A single table, with the reasoning for each figure, would let teams and families give the same answer."@en ;
  schema:url <https://onco.cc/ideas/idea-pu-lutetium-177-family-planning-table/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14908037-2892-4d98-a053-253ce35afb1a>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72d1a024-00b7-418a-b36e-b2cb48f2ab55>, <https://doi.org/10.1007/s00259-023-06255-8>, <https://doi.org/10.1007/s00259-012-2330-6> ;
  onco:tag "protocol-upgrade", "upgrade:untested", "evidence:insufficient" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/neuroendocrine/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/fertility-preservation/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/>, <https://onco.cc/drugs/lutathera/> ;
  onco:institutions <https://onco.cc/institutions/eanm/>, <https://onco.cc/institutions/snmmi/>, <https://onco.cc/institutions/iaea/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-knowledge-diffusion/> .